生技公司
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionTHRIVENT SERIES FUND INC - Thrivent Moderate Allocation Portfolio Class A
Latest Disclosed Ownership11,685 shares
Latest Disclosed Value $ 601,193
THRIVENT SERIES FUND INC - Thrivent Moderate Allocation Portfolio Class A reports 2.78% decrease in ownership of TECH / Bio-Techne Corporation

On August 27, 2025 - THRIVENT SERIES FUND INC - Thrivent Moderate Allocation Portfolio Class A filed a NPORT-P form disclosing ownership of 11,685 shares of Bio-Techne Corporation (US:TECH) valued at $601,193 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 12,019 shares of Bio-Techne Corporation. This represents a change in shares of -2.78% during the quarter. The current value of the position is $607,503 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Bio-Techne EC US09073M1045 11,685 -334 -2.78 601 -14.63 0.0068
2025-05-28 2025-03-31 NP Bio-Techne EC US09073M1045 12,019 0 0.00 705 -18.61 0.0082
2025-02-26 2024-12-31 NP Bio-Techne EC US09073M1045 12,019 -7,056 -36.99 866 -43.24 0.0095
2024-11-26 2024-09-30 NP Bio-Techne EC US09073M1045 19,075 -41,369 -68.44 1,525 -64.80 0.0159
2024-08-27 2024-06-28 NP Bio-Techne EC US09073M1045 60,444 4,535 8.11 4,331 10.04 0.0463
2024-05-29 2024-03-28 NP Bio-Techne EC US09073M1045 55,909 5,502 10.92 3,935 1.18 0.0412
2024-02-27 2023-12-29 NP Bio-Techne EC US09073M1045 50,407 -2,567 -4.85 3,889 7.88 0.0418
2023-11-28 2023-09-29 NP Bio-Techne EC US09073M1045 52,974 4,351 8.95 3,606 -9.17 0.0409
2023-08-28 2023-06-30 NP Bio-Techne EC US09073M1045 48,623 5,388 12.46 3,969 23.76 0.0426
2023-05-25 2023-03-31 NP Bio-Techne EC US09073M1045 43,235 0 0.00 3,208 -10.49 0.0349
2023-02-28 2022-12-30 NP Bio-Techne EC US09073M1045 43,235 32,610 306.92 3,583 18.76 0.0400
2022-11-28 2022-09-30 NP Bio-Techne EC US09073M1045 10,625 205 1.97 3,018 -16.45 0.0346
2022-08-25 2022-06-30 NP Bio-Techne EC US09073M1045 10,420 -34 -0.33 3,612 -20.23 0.0390
2022-05-27 2022-03-31 NP Bio-Techne EC US09073M1045 10,454 -608 -5.50 4,527 -20.88 0.0418
2022-02-25 2021-12-31 NP Bio-Techne EC US09073M1045 11,062 -10,146 -47.84 5,723 -44.32 0.0491
2021-11-24 2021-09-30 NP Bio-Techne EC US09073M1045 21,208 -779 -3.54 10,277 3.81 0.0903
2021-08-26 2021-06-30 NP Bio-Techne EC US09073M1045 21,987 2,608 13.46 9,900 33.75 0.0861
2021-05-27 2021-03-31 NP Bio-Techne EC US09073M1045 19,379 -18,329 -48.61 7,401 -38.19 0.0669
2021-02-26 2020-12-31 NP Bio-Techne EC US09073M1045 37,708 7,500 24.83 11,974 60.02 0.1088
2020-11-25 2020-09-30 NP Bio-Techne EC US09073M1045 30,208 -430 -1.40 7,483 -7.50 0.0726
2020-08-28 2020-06-30 NP Bio-Techne EC US09073M1045 30,638 -13,404 -30.43 8,091 -3.13 0.0810
2020-05-28 2020-03-31 NP Bio-Techne EC US09073M1045 44,042 826 1.91 8,351 -11.97 0.0935
2020-02-28 2019-12-31 NP Bio-Techne EC 09073M104 43,216 674 1.58 9,486 13.96 0.0907
2019-11-22 2019-09-30 NP Bio-Techne EC US09073M1045 42,542 42,542 8,324 0.0820
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.